Twitxy Saved

Jon Watts

@jwattsgroup

Oligonucleotide Therapeutics and Chemical Biology. Find us also at @jwattsgroup.bsky.social
Worcester, MA umassmed.edu/wattslab Joined March 2013
235 Following 937 Followers 410 Posts

Latest posts 5

Jon Watts @jwattsgroup
Seems like they missed an opportunity here -- they could have called the combined company the Ornery Renegades... @orna_tx @ReNAgadeTx #RNA
ReNAgade Therapeutics is acquired by RNA rival Orna Therapeutics a year after launching with $300M. The combined startup will focus on in vivo CAR-T cells and an in vivo gene editing therapy for sickle cell disease. More details in my story for @endpts
endpts.com/renagade-is-ac…
View quoted post on X
0 replies 0 reposts 10 likes 736 views View on X
Jon Watts @jwattsgroup
In the latest paper from senior PhD student @Samantha_Sarli, we compare the activity profile of conjugated and unconjugated ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo. Amphiphilic lipids help drive safe uptake! Online now at NAR: academic.oup.com/nar/article/do…
academic.oup.com Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in... Abstract. Glioblastoma multiforme is a universally lethal brain tumor that largely resists current surgical and drug interventions. Despite important advan
2 replies 8 reposts 49 likes 5.9K views View on X